Goldman Sachs: XPENG-W (09868) first quarter revenue guidance exceeds expectations, rating it as "buy" with a target price of 85 Hong Kong dollars.
The company expects investors to focus on Xiaopeng Motors' first quarter gross profit margin guidance, the future development of humanoid robots and autonomous driving, as well as the timing of new car releases and overseas expansion strategies for the whole year.
Goldman Sachs released a research report stating that the gross profit and EBIT of XPENG-W (09868) in the fourth quarter of 2025 exceeded the bank's and market expectations, mainly due to higher than expected service and other income, as well as increased government subsidies. Although the guidance for first quarter deliveries in 2026 is lower at 61,000 to 66,000 vehicles, the revenue guidance of 12.2 billion to 13.28 billion RMB exceeds the bank's expectations, possibly driven by non-automobile income. The bank has given a "buy" rating and a Hong Kong target price of 85 Hong Kong dollars. The bank expects investors to focus on XiaoPeng Motors' first quarter gross margin guidance, future milestones in humanoid robots and autonomous driving, as well as the timing of new car model releases and overseas expansion strategies for the whole year.
Related Articles
PEGBIO CO-B(02565) annual performance published. Research and development expenditure was 50.387 million yuan. A drug pipeline matrix covering seven drugs in the field of chronic diseases has been successfully established.
TINGYI (00322) announces its performance for the year 2025, with a net profit attributable to shareholders of approximately 4.5 billion yuan, representing a year-on-year growth of 20.5%. It plans to distribute a final dividend and a special final dividend of 39.92 cents per share.
HK FINANCE GP (01273) granted a loan of HK $40 million principal amount.
PEGBIO CO-B(02565) annual performance published. Research and development expenditure was 50.387 million yuan. A drug pipeline matrix covering seven drugs in the field of chronic diseases has been successfully established.
TINGYI (00322) announces its performance for the year 2025, with a net profit attributable to shareholders of approximately 4.5 billion yuan, representing a year-on-year growth of 20.5%. It plans to distribute a final dividend and a special final dividend of 39.92 cents per share.
HK FINANCE GP (01273) granted a loan of HK $40 million principal amount.
